seed
Stage
3
Investors
About
Ingenix develops a multimodal and multiscale generative AI platform to simulate clinical drug trials, predicting clinical endpoints and adverse events from molecular through population levels.
Explore Ingenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.